Press Releases Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-17 pm EDT			5-day change	1st Jan Change
2.35 ^USD	-3.29%		+0.64%	-36.31%

May. 13	Barinthus Biotherapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 01	Barinthus Biotherapeutics plc Appoints Leon Hooftman as Chief Medical Officer, Effective from Beginning of June 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments	May. 13	GL
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer	May. 01	GL
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer	May. 01	AQ
Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections	Apr. 18	GL
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments	Mar. 20	GL
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones	Jan. 05	GL
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones	Jan. 05	AQ
New partnership aims to advance vaccine against MERS coronavirus	Dec. 21	GL
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD	Nov. 09	GL
Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments	Nov. 09	GL
Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer	Nov. 06	GL
Are we globally prepared for the next pandemic?	23-10-30	AQ
Thinking about buying stock in Pliant Therapeutics, Esperion Therapeutics, Murphy Canyon Acquisition Corp, Limbach Holdings, or Vaccitech?	23-09-26	PR
Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023	23-09-13	GL
Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023	23-09-13	AQ
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments	23-08-10	GL
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B	23-06-21	GL
Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy	23-06-12	GL
Vaccitech Reports First Quarter 2023 Financial Results and Recent Corporate Developments	23-05-12	AQ
VACCITECH PLC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-04-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Press Releases

Filters